Professor and co-founder of ANYO Labs Leif A. Eriksson has successfully identified a novel kinase inhibitor that kills Glioblastoma cells by stressing them to death.
We are thrilled to share that Professor Leif Eriksson, one of our esteemed founders at ANYO Labs, has achieved remarkable breakthroughs in his research on targeting the Glioblastoma tumor—a devastating and challenging brain cancer to treat. His work is a testament to the incredible dedication and expertise of our team in advancing early-stage drug discovery.
We are honored to have Professor Eriksson as part of the ANYO Labs family, driving our technology to new heights.
Curious to learn more about the recent breakthroughs? Don't miss the full publication following the link below.